Regarding prognosis, Kaplan-Meier analysis also revealed that LGALS3 was a significant poor prognostic marker in diffusely infiltrating glioma, and it was a clear indicator of poor prognosis in both LGG and GBM regardless of whether chemotherapy was used (Figure 5). This evidence concerns the gene LGALS3 and central nervous system cancer.